ERS Genomics appoints John E Milad as Chief Executive Officer

FHS
May 13, 2024
11:00 am

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

Chatbots Fail Standard Cognitive Test

President-elect Donald Trump may have once scored a perfect 30/30 on the Montreal Cognitive Assessment (MoCA), but artificial intelligence (AI) chatbots didn’t perform nearly as

December 19, 2024

Study explores why teens self-diagnose mental health conditions through TikTok content

Adolescents are increasingly self-diagnosing mental health conditions after engaging with TikTok, driven by identity exploration and limited healthcare access.

October 18, 2024

Immunomodulatory effects of PFAS can impair health

Because they are persistant, per- and polyfluoroalkyl substances (PFAS) are also known as “chemicals for eternety”.

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.